-
Featured Authors
-
Archives
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Tag Archives: counterfeit
Counterfeiting: White House IP Czar Victoria Espinel on working with corporations
White house IP Czar Victoria Espinel spoke at BIO’s 2011 International Convention in a session titled Counterfeiting: How corporations and government can work together. She told the audience that when entering her new assignment she was surprised to find out that counterfeiting was a large problem in the United States and not just abroad. The Administration has increased enforcement in counterfeit medicines as seizures of health related counterfeits have gone up 97% from last year. Read More >
U.S. Inter-Agency Group takes on Counterfeit Pharmaceuticals
The Office of the Intellectual Property Enforcement Coordinator released an Inter-Agency report partnering with the Food and Drug Administration, U.S. Customs and Border Protection, U.S. Immigration and Customs Enforcement, and the Departments of Justice, State, and Commerce and USAID. The report highlights the Administration’s efforts to combat counterfeit pharmaceuticals listing various Department initiatives and in some cases providing actual budget numbers (State Department budgets $1.3 million in 2011 to combat counterfeit pharmaceuticals). Finally, the report Read More >
Patently BIOtech
1 Comment
Email This Post
Tags: CBP, congress, counterfeit, counterfeit drugs, counterfeit pharmaceuticals, Counterfeits, Department of Commerce, Department of Justice, Department of State, FDA, Food and Drug Administration, Inter-Agency, IP Czar, Joe Biden, mandatory disclosure, Office of the Intellectual Property Enforcement Coordinator, State Department, U.S. Customs and Border Protection, U.S. Immigration and Customs Enforcement, USAID, Vice President, Victoria Espinel
Tags: CBP, congress, counterfeit, counterfeit drugs, counterfeit pharmaceuticals, Counterfeits, Department of Commerce, Department of Justice, Department of State, FDA, Food and Drug Administration, Inter-Agency, IP Czar, Joe Biden, mandatory disclosure, Office of the Intellectual Property Enforcement Coordinator, State Department, U.S. Customs and Border Protection, U.S. Immigration and Customs Enforcement, USAID, Vice President, Victoria Espinel
